ReportAId

ReportAId

Private
Milan, LombardyEnterprise Softwarehttps://www.reportaid.ai

Last Round

Pre Seed

May 6, 2025

Total Funding Raised

$2.49M

Momentum Score

25 /100

Company Overview

ReportAId is an Italian health-tech company that has developed an AI-powered software platform to address healthcare inefficiencies. The platform interprets unstructured medical reports, such as clinical notes and physician narratives, and transforms them into structured, actionable data. This enables the creation of personalized care pathways, automates workflows, and provides valuable insights for healthcare providers to improve patient outcomes and operational efficiency. The company's solution helps hospitals and clinics enhance patient management, streamline appointments, and increase revenue. Founded in 2024 and based in Milan, ReportAId secured a €2.2 million pre-seed funding round in May 2025 to expand its team and scale its operations across Italy and Europe.

Sector

Enterprise Software

Verticals

Medical AI, Healthcare Analytics, Patient Engagement, NLP & Conversational AI

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

clinical NLPunstructured data analysisclinical data extractionautomated care plansmedical AIhealthcare analyticspatient relationship managementPRMrevenue cycle managementcare coordinationclinical intelligencemedication extractionhospital CRM integrationBI integrationreport compliancephysician burnoutHealthTech AIenterprise healthcare software

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ReportAId Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

ReportAId Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Pre SeedMay 6, 2025

Key People

Founding team and executive leadership

Claudio Caletti

CTO And Founder

Founding Team

Giuseppe Faraci

CEO Founder

Founding Team

ReportAId Investors

Notable investors and investment history

InvestorRounds
HeartfeltPre Seed
B HeroesPre Seed
Exceptional VenturesPre Seed
VentoPre Seed
Vesper Holding S.r.l.Pre Seed
2100 VenturesPre Seed
Vento VenturesPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 24, 2025

    Added Ospedaleisolatiberina, a mid-market healthcare provider, as a customer.

  • Dec 24, 2025

    Added Medicaltown, a startup in the healthcare sector, as a customer.

ReportAId Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

ReportAId Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ReportAId's valuation, stock price, and market status.

Firmographic Details

HeadquartersMilan, Lombardy
Employee Range16
Year Founded2024
Last FundingMay 6, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.